Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein

被引:1
|
作者
Romero, Atilio Reyes [1 ,2 ]
Kubica, Katarzyna [1 ]
Kitel, Radoslaw [1 ]
Rodriguez, Ismael [1 ]
Magiera-Mularz, Katarzyna [1 ]
Domling, Alexander [2 ]
Holak, Tad A. [1 ]
Surmiak, Ewa [1 ]
机构
[1] Jagiellonian Univ, Fac Chem, Dept Organ Chem, Gronostajowa 2, PL-30387 Krakow, Poland
[2] Univ Groningen, Dept Drug Design, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands
来源
MOLECULES | 2022年 / 27卷 / 23期
关键词
protein-protein interactions; anti-cancer therapy; nuclear magnetic resonance; protein-peptide docking; small-molecule inhibitors; DRUG DISCOVERY; UBL5; GENE; UBIQUITIN; DOCKING; RECOGNITION; PEPTIDES; BINDING;
D O I
10.3390/molecules27238282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By binding to the spliceosomal protein Snu66, the human ubiquitin-like protein Hub1 is a modulator of the spliceosome performance and facilitates alternative splicing. Small molecules that bind to Hub1 would be of interest to study the protein-protein interaction of Hub1/Snu66, which is linked to several human pathologies, such as hypercholesterolemia, premature aging, neurodegenerative diseases, and cancer. To identify small molecule ligands for Hub1, we used the interface analysis, peptide modeling of the Hub1/Snu66 interaction and the fragment-based NMR screening. Fragment-based NMR screening has not proven sufficient to unambiguously search for fragments that bind to the Hub1 protein. This was because the Snu66 binding pocket of Hub1 is occupied by pH-sensitive residues, making it difficult to distinguish between pH-induced NMR shifts and actual binding events. The NMR analyses were therefore verified experimentally by microscale thermophoresis and by NMR pH titration experiments. Our study found two small peptides that showed binding to Hub1. These peptides are the first small-molecule ligands reported to interact with the Hub1 protein.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction
    Wells, Geoff
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 : 674 - 679
  • [32] Screening of Small-Molecule Inhibitors of Protein-Protein Interaction with Capillary Electrophoresis Frontal Analysis
    Xu, Mei
    Liu, Chao
    Zhou, Mi
    Li, Qing
    Wang, Renxiao
    Kang, Jingwu
    ANALYTICAL CHEMISTRY, 2016, 88 (16) : 8050 - 8057
  • [33] Computer-Aided Discovery of Small Molecule Inhibitors of Transcriptional Activity of TLX (NR2E1) Nuclear Receptor
    Dueva, Evgenia
    Singh, Kriti
    Kalyta, Anastasia
    LeBlanc, Eric
    Rennie, Paul S.
    Cherkasov, Artem
    MOLECULES, 2018, 23 (11):
  • [34] Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation
    Kalmode, Hanuman P.
    Podsiadly, Izabella
    Kabra, Ashish
    Boulton, Adam
    Reddy, Prabhakar
    Gao, Yan
    Li, Christopher
    Bushweller, John H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1363 - 1369
  • [35] Small-Molecule Inhibitors of the m7G-RNA Writer METTL1
    Nai, Francesco
    Espinoza, Maria Paula Flores
    Invernizzi, Annalisa
    Vargas-Rosales, Pablo Andres
    Bobileva, Olga
    Herok, Marcin
    Caflisch, Amedeo
    ACS BIO & MED CHEM AU, 2023, 4 (02): : 100 - 110
  • [36] An updated review of small-molecule HPK1 kinase inhibitors (2016-present)
    Duan, Yiping
    Guo, Zhichao
    Zhong, Wenyi
    Chen, Jichao
    Xu, Shengtao
    Liu, Jie
    Xu, Jinyi
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (22) : 2431 - 2450
  • [37] Identification of small-molecule protein-protein interaction inhibitors for NKG2D
    Thompson, Aaron A.
    Harbut, Michael B.
    Kung, Pei-Pei
    Karpowich, Nathan K.
    Branson, Jeffrey D.
    Grant, Joanna C.
    Hagan, Deborah
    Pascual, Heather A.
    Bai, Guoyun
    Zavareh, Reza Beheshti
    Coate, Heather R.
    Collins, Bernard C.
    Cote, Marjorie
    Gelin, Christine F.
    Damm-Ganamet, Kelly L.
    Gholami, Hadi
    Huff, Adam R.
    Limon, Luis
    Lum, Kevin J.
    Mak, Puiying A.
    Nakafuku, Kohki M.
    V. Price, Edmund
    Shih, Amy Y.
    Tootoonchi, Mandana
    Vellore, Nadeem A.
    Wang, Jocelyn
    Wei, Na
    Ziff, Jeannie
    Berger, Scott B.
    Edwards, James P.
    Gardet, Agnes
    Sun, Siquan
    Towne, Jennifer E.
    Venable, Jennifer D.
    Shi, Zhicai
    Venkatesan, Hariharan
    Rives, Marie-Laure
    Sharma, Sujata
    Shireman, Brock T.
    Allen, Samantha J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (18)
  • [38] Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domain
    Shukla, Shirish
    Ying, Weijiang
    Gray, Felicia
    Yao, Yiwu
    Simes, Miranda L.
    Zhao, Qingjie
    Miao, Hongzhi
    Cho, Hyo Je
    Gonzalez-Alonso, Paula
    Winkler, Alyssa
    Lund, George
    Purohit, Trupta
    Kim, EunGi
    Zhang, Xiaotian
    Ray, Joshua M.
    He, Shihan
    Nikolaidis, Caroline
    Ndoj, Juliano
    Wang, Jingya
    Jaremko, Lukasz
    Jaremko, Mariusz
    Ryan, Russell J. H.
    Guzman, Monica L.
    Grembecka, Jolanta
    Cierpicki, Tomasz
    NATURE CHEMICAL BIOLOGY, 2021, 17 (07) : 784 - 793
  • [39] Recent Advances in the Development of Small-Molecule Compounds Targeting HIV-1 gp41 as Membrane Fusion Inhibitors
    Kawashita, Norihito
    Tian, Yu-Shi
    de Silva, U. Chandimal
    Okamoto, Kousuke
    Takagi, Tatsuya
    MINI-REVIEWS IN ORGANIC CHEMISTRY, 2012, 9 (01) : 20 - 26
  • [40] Design of small-molecule thrombin inhibitors based on the cis-5-phenylproline scaffold
    Kudryavtsev, K. V.
    Shulga, D. A.
    Chupakhin, V. I.
    Churakov, A. V.
    Datsuk, N. G.
    Zabolotnev, D. V.
    Zefirov, N. S.
    RUSSIAN CHEMICAL BULLETIN, 2011, 60 (04) : 685 - 693